PharmAthene battles for anthrax vaccine bucks
PharmAthene has stated its desire to compete for a government anthrax vaccine manufacturing contract, which could be worth up to $600m.
PharmAthene has stated its desire to compete for a government anthrax vaccine manufacturing contract, which could be worth up to $600m.
Mere weeks after signing major strategic collaborations with contract service firms Covance, Quintiles and 3i, Eli Lilly has journeyed further down the outsourcing route – albeit with a different spin – by forging another agreement with India’s Jubilant...
AkzoNobel has been awarded a good manufacturing practice (GMP) certificate for Sanal (sodium chloride) salt manufactured at its plant in Mariager, Denmark.
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Malvern, Caen, Finesse and Bausch.
The much-trumpeted partnership between China’s WuXi PharmaTech and Covance to provide ‘world class preclinical research services’ has been called off.
Two chemical company directors have been sentenced for not notifying authorities that their company produced a substance controlled under the Chemical Weapons Convention (CWC).